European Journal of Medical Research aims to support and publish research into the causes, characteristics, diagnosis and treatment of human disorders and disease. We will consider translational, preclinical and clinical research across all medical disciplines, enabling clinicians and other researchers to learn about developments and innovations within and across the boundaries between these disciplines. European Journal of Medical Research publishes high quality ethically-conducted research and reviews and aims to ensure that the results of all well-conducted research are published, regardless of their outcome.
Articles
-
-
Bruceine D inhibits hepatocellular carcinoma by regulating the STAT3 signaling pathway through HSP70
-
Dysregulation of mineral metabolism: association of albumin-corrected calcium and vitamin D with diabetic kidney disease in type 2 diabetes—a cross-sectional study
-
Novel inflammation biomarkers in adult minimal change disease: predicting steroid-resistance and relapse
-
Development and validation of a risk prediction model for co-existing depression in middle-aged and older adults with low back pain
-
A review of neurological side effects of COVID-19 vaccination
-
Face masks: benefits and risks during the COVID-19 crisis
-
Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis
-
Evaluation of preoperative anxiety and fear of anesthesia using APAIS score
-
Management of proximal femur fractures in the elderly: current concepts and treatment options
Join the Editorial Board
We are recruiting Associate Editors to join our Editorial Board. Learn more about the role and how to apply here!
Article of the Month: Tranexamic acid in spontaneous intracerebral hemorrhage: a meta-analysis
The potential benefit of tranexamic acid in patients with spontaneous intracerebral hemorrhage remains an important and actively investigated topic. This updated meta-analysis incorporated five randomized controlled trials, including the recent STOP-MSU trial. The analysis demonstrated that tranexamic acid does not significantly reduce hematoma expansion or improve clinical outcomes in patients with spontaneous intracerebral hemorrhage. Although tranexamic acid is inexpensive and widely accessible, current evidence does not support its routine use in the management of spontaneous intracerebral hemorrhage. Further research is warranted to identify subgroups of patients who may benefit from targeted antifibrinolytic therapy.
Aims and scope
Sign up to article alerts
European Journal of Medical Research is published continuously online-only. We encourage you to sign up to receive free email alerts to keep up to date with all of the latest articles by registering here.
Trending articles
Check out the most discussed articles from European Journal of Medical Research in the past 6 months!
Annual Journal Metrics
-
Citation Impact
Journal Impact Factor: 3.4 (2024)
5-year Journal Impact Factor: 3.4 (2024)Speed
Submission to first editorial decision (median days): 10
Submission to acceptance (median days): 129Usage 2024
Downloads: 2,400,811
Altmetric mentions: 2,214